Der blev fremlagt en ny undersøgelsesrapport, som konkluderede, at anvendelse af venlafaxin ikke var forbundet med en merrisiko for pludselig hjertedød sammenlignet med SSRI' erne fluoxetin og citalopram eller dusolepin hos patienter med depression eller angst.
A new study report was provided which concluded that the use of venlafaxine was not associated with an excess risk of sudden cardiac death compared with the SSRIs fluoxetine and citalopram or dusolepin in patients with depression or anxiety.